Handelsavisen
prelaunch
Companies Healthcare 328130.KQ
32
328130.KQ KOSDAQ Advanced Medical Equipment & Technology

Lunit Inc

$17 900,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
665,7B KRW
P/E
EV / Rev
Div yield
0,00 %
Op margin
-100,0 %
ROE
-34,5 %
Net margin
-57,0 %
Debt / equity
0,81
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Lunit Inc is a South Korean company that develops artificial intelligence (AI) solutions for the healthcare industry, primarily focusing on medical imaging and diagnostics.

Business. Lunit Inc (328130.KQ) is a healthcare company specializing in advanced medical equipment and technology, primarily operating within the healthcare services and equipment sector. The firm generates revenue through the sale of healthcare equipment products. Lunit is headquartered in South Korea and is listed on the KOSDAQ exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
SELL1 analysts
0 buy0 hold1 sell
Avg 12m price target28 090,92

Analyst recommendations

1 analysts · consensus Sell
Buy0
Hold0
Sell1
12-month price target
28 090,92
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Sell
1 analysts · indicative
Ownership
not yet wired
Profitability
-34,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 328130.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 328130.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Lunit Inc (328130.KQ) is a healthcare company specializing in advanced medical equipment and technology, primarily operating within the healthcare services and equipment sector. The firm generates revenue through the sale of healthcare equipment products. Lunit is headquartered in South Korea and is listed on the KOSDAQ exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    Lunit Inc has a price-to-book ratio of 4.84, indicating that the market values the company at nearly five times its book value. The company's liquidity position is weak, with a current ratio of 0.26, suggesting that it has insufficient short-term assets to cover its short-term liabilities. Additionally, the company has a negative net cash position after subtracting total debt, which raises concerns about its ability to meet short-term obligations.

    The company's profitability is severely challenged, with a return on equity (ROE) of -0.3448 and a return on assets (ROA) of -0.1281, both of which are negative and significantly below industry norms. The operating income is negative at -83.1 billion KRW, and the net income is also negative at -47.4 billion KRW, indicating that the company is not generating profits from its core operations.

    Lunit Inc's revenue is concentrated in a single business segment, as disclosed in its financial reports, with no significant geographic diversification mentioned. This lack of diversification increases the company's exposure to market-specific risks and could impact its long-term stability.

    The company's growth trajectory is uncertain, with no clear indication of revenue growth in the current fiscal year. The operating cash flow is negative at -55.2 billion KRW, and the free cash flow is also negative at -46.7 billion KRW, indicating that the company is not generating sufficient cash from its operations to fund its activities. The capital expenditure of -9.63 billion KRW suggests that the company is investing in its operations, but the negative value indicates that these investments are not yet generating positive returns.

    The risk assessment for Lunit Inc highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.81 indicates a moderate level of leverage, but the negative net cash position after subtracting total debt is a red flag. The company has not issued any new shares recently, and there is no indication of dilution pressure in the near term.

    Recent events, including analyst estimates, suggest a cautious outlook for the company. The mean price target of 28,090.92 KRW is significantly higher than the current market price of 17,900 KRW, indicating that analysts expect some upside potential. However, the mean recommendation of 4.00 (on a scale of 1 to 5) suggests a neutral to bearish sentiment among analysts.

    Key takeaways
    • Lunit Inc is trading at a price-to-book ratio of 4.84, suggesting a premium valuation relative to its book value.
    • The company's liquidity position is weak, with a current ratio of 0.26 and a negative net cash position after subtracting total debt.
    • Lunit Inc is not profitable, with a negative return on equity and return on assets, and a negative operating and net income.
    • The company's revenue is concentrated in a single business segment, increasing its exposure to market-specific risks.
    • Analysts have a neutral to bearish outlook, with a mean recommendation of 4.00 and a mean price target of 28,090.92 KRW.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $17 900,00
    Market cap
    $665.72B
    Enterprise value
    $763.20B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    4.8x
    P / Tangible book
    4.8x
    Tangible book
    $137.43B
    Net cash
    -$97.47B
    Current ratio
    0.3
    Debt / equity
    0.8
    ROA
    -12.8%
    ROE
    -34.5%
    Cash conversion
    116.0%
    CapEx / revenue
    -11.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -2 085,91
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    1
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-22 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate-2 085,91
    Revenueno estimateno estimate96,1B KRW
    Operating incomeno estimateno estimate-44,4B KRW
    Full-year consensus mean (period as reported by source) · consensus in KRW. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy0
    Buy0
    Hold0
    Sell1
    Strong sell0
    12-month price target$28 090,92 · Median $28 090,92
    Low $28 090,92High $28 090,92
    Operating income · consensus-44,4B KRW
    EPS surprise
    −18,7 %
    reported vs consensus · miss
    Revenue surprise
    −13,5 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$28 090,92
    Mean$28 090,92
    Median$28 090,92
    High$28 090,92
    Spot$17 900,00
    +56.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-100,0 %Below median
    Net Margin-57,0 %Below median
    ROE-34,5 %Below median
    Capex / Rev-11,6 %Bottom quartile
    D/E0,81Bottom quartile
    Cash Conv1,16Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • Lunit Inc Market data — financials · 2026-05-26
    • Lunit Inc Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    328130.KQCanonical
    KOSDAQ · KRW

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage